Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 13
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Separating actin-dependent chemokine receptor nanoclustering from dimerization indicates a role for clustering in CXCR4 signaling and function.

  • Martínez Muñoz, Laura
  • Rodríguez-Frade, José Miguel
  • Barroso Rodríguez, Rubén
  • Sorzano, Carlos Óscar S.
  • Torreño-Pina, José A.
  • Santiago, César
  • Manzo, Carlo
  • Lucas, Pilar
  • García-Cuesta, Eva María
  • Gutierrez, Enric
  • Barrio, Laura
  • Vargas, Javier
  • Cascio, Graciela
  • Carrasco, Yolanda R.
  • Sánchez Madrid, Francisco
  • Garcia-Parajo, Maria F.
  • Mellado, Mario
A current challenge in cell motility studies is to understand the molecular and physical mechanisms that govern chemokine receptor nanoscale organization at the cell membrane, and their influence on cell response. Using single-particle tracking and super-resolution microscopy, we found that the chemokine receptor CXCR4 forms basal nanoclusters in resting T cells, whose extent, dynamics, and signaling strength are modulated by the orchestrated action of the actin cytoskeleton, the co-receptor CD4, and its ligand CXCL12. We identified three CXCR4 structural residues that are crucial for nanoclustering and generated an oligomerization-defective mutant that dimerized but did not form nanoclusters in response to CXCL12, which severely impaired signaling. Overall, our data provide new insights to the field of chemokine biology by showing that receptor dimerization in the absence of nanoclustering is unable to fully support CXCL12-mediated responses, including signaling and cell function in vivo, This work was supported by grants from the Spanish Ministry of Economy and Competitiveness (SAF 2014-53416-R, SAF 2017-82940-R AEI/FEDER, EU) and the RETICS Program (RD16/0012/0006; RIER), Ministry of Economy and Competitiveness, Severo Ochoa Programme for Centres of Excellence in R&D (SEV-2013-0347; SEV-2015-0522), and Fundación Privada Cellex and Generalitat de Catalunya (CERCA program). L.M.-M. is supported by the COMFUTURO program of the Spanish Research Council General Foundation., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

SARS-Cov-2 cysteine-like protease (Mpro) is immunogenic and can be detected in serum and saliva of COVID-19-seropositive individuals, SARS-CoV-2 protease antibodies in serum and saliva

  • Martinez-Fleta, Pedro
  • Alfranca, Arántzazu
  • González-Álvaro, Isidoro
  • Casasnovas, José María
  • Fernández-Soto, Daniel
  • Esteso, Gloria
  • Cáceres-Martell, Yaiza
  • Gardeta, Sofía
  • Prat, Salomé
  • Mateu-Alberoa, Tamara
  • Gabrie, Ligia
  • López-Granados, Eduardo
  • Sánchez-Madrid, Francisco
  • Rodríguez-Frade, José Miguel
  • Reyburn, H. T.
  • Valés-Gómez, Mar
Currently, there is a need for reliable tests that allow identification of individuals that have been infected with SARS-CoV-2 even if the infection was asymptomatic. To date, the vast majority of the serological tests for SARS-CoV-2 specific antibodies are based on serum detection of antibodies to either the viral spike glycoprotein (the major target for neutralising antibodies) or the viral nucleocapsid protein that are known to be highly immunogenic in other coronaviruses. Conceivably, exposure of antigens released from infected cells could stimulate antibody responses that might correlate with tissue damage and, hence, they may have some value as a prognostic indicator. We addressed whether other non-structural viral proteins, not incorporated into the infectious viral particle, specifically the viral cysteine-like protease, might also be potent immunogens. Using ELISA tests, coating several SARS-CoV-2 proteins produced in vitro, we describe that COVID-19 patients make high titre IgG, IgM and IgA antibody responses to the Cys-like protease from SARS-CoV-2, also known as 3CLpro or Mpro, and it can be used to identify individuals with positive serology against the coronavirus. Higher antibody titres in these assays associated with more severe disease and no cross-reactive antibodies against prior betacoronavirus were found. Remarkably, IgG antibodies specific for Mpro and other SARS-CoV-2 antigens can also be detected in saliva. In conclusion, Mpro is a potent antigen in infected patients that can be used in serological tests and its detection in saliva could be the basis for a rapid, non-invasive test for COVID-19 seropositivity., This work was supported by the Spanish National Research Council (CSIC, project number 202020E079) and grants from Madrid Regional Government IMMUNOTHERCAN [S2017/BMD-3733-2 (MVG)]; the Spanish Ministry of Science and Innovation [(MCIU/AEI/FEDER, EU): RTI2018-093569-B-I00 (MVG), SAF2017-82940-R (JMRF), SAF2017-83265-R (HTR); SAF2017-82886-R (FSM)]; RETICS Program of ISCIII [RD16/0012/0006; RIER (JMRF); RD16/0011/0012, PI18/0371 (IGA), PI19/00549 (AA)]. The study was also funded by La Caixa Banking Foundation (HR17-00016 to FSM) and Fondo Supera COVID (CRUE-Banco de Santander) to FSM, No
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Identification of a Human SOCS1 Polymorphism That Predicts Rheumatoid Arthritis Severity

  • Lamana, Amalia
  • Villares, Ricardo
  • Seoane, Iria V.
  • Andrés, Nuria de
  • Lucas, Pilar
  • Emery, Paul
  • Vital, Edward M.
  • Triguero-Martínez, Ana
  • Márquez, Ana
  • Ortiz, Ana M.
  • Maxime, Robin
  • Martínez, Carmen
  • Martín, J.
  • Gomariz, Rosa P.
  • Ponchel, Frederique
  • González-Álvaro, Isidoro
  • Mellado, Mario
Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by an autoimmune response in the joints and an exacerbation of cytokine responses. A minority of patients with RA experience spontaneous remission, but most will show moderate/high disease activity, with aggressive joint damage and multiple systemic manifestations. There is thus is a great need to identify prognostic biomarkers for disease risk to improve diagnosis and prognosis, and to inform on the most appropriate therapy. Here we focused on suppressor of cytokine signaling 1 (SOCS1), a physiological negative regulator of cytokines that modulates cell activation. Using four independent cohorts of patients with arthritis, we characterized the correlation between SOCS1 mRNA levels and clinical outcome. We found a significant inverse correlation between SOCS1 mRNA expression and disease activity throughout the follow-up of patients with RA. Lower baseline SOCS1 levels were associated with poorer disease control in response to methotrexate and other conventional synthetic disease-modifying anti-rheumatic drugs in early arthritis, and to rituximab in established (active) RA. Moreover, we identified several single nucleotide polymorphisms in the SOCS1 gene that correlated with SOCS1 mRNA expression, and that might identify those patients with early arthritis that fulfill RA classification criteria. One of them, rs4780355, is in linkage disequilibrium with a microsatellite (TTTTC), mapped 0.9 kb downstream of the SNP, and correlated with reduced SOCS1 expression in vitro. Overall, our data support the association between SOCS1 expression and disease progression, disease severity and response to treatment in RA. These observations underlie the relevance of SOCS1 mRNA levels for stratifying patients prognostically and guiding therapeutic decisions., This work was supported in part by grants from the Spanish Ministry of Economy and Competitiveness/FEDER (SAF 2017-82940-R; PI14/00442, PI17/00027, PI18/00371), the RETICS Program of the Instituto de Salud Carlos III (RIER: RD16/0012/0006; RD16/0012/0008; RD16/0012/0011; RD16/0012/0013) and the European Union (Masterswitch FP7-Health-2007-B-223404). We also obtained funds from the Spanish Natonal Research Council for open access publication fees
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

SARS-CoV-2 Cysteine-like Protease Antibodies Can Be Detected in Serum and Saliva of COVID-19–Seropositive Individuals

  • Martinez-Fleta, Pedro
  • Alfranca, Arántzazu
  • González-Álvaro, Isidoro
  • Casasnovas, José María
  • Fernández-Soto, Daniel
  • Esteso, Gloria
  • Cáceres-Martell, Yaiza
  • Gardeta, Sofía
  • López-Sanz, Celia
  • Prat, Salomé
  • Mateu-Alberoa, Tamara
  • Gabrie, Ligia
  • López-Granados, Eduardo
  • Sánchez-Madrid, Francisco
  • Reyburn, H. T.
  • Rodríguez-Frade, José Miguel
  • Valés-Gómez, Mar
Currently, there is a need for reliable tests that allow identification of individuals that have been infected with SARS-CoV-2 even if the infection was asymptomatic. To date, the vast majority of the serological tests for SARS-CoV-2–specific Abs are based on serum detection of Abs to either the viral spike glycoprotein (the major target for neutralizing Abs) or the viral nucleocapsid protein that is known to be highly immunogenic in other coronaviruses. Conceivably, exposure of Ags released from infected cells could stimulate Ab responses that might correlate with tissue damage and, hence, they may have some value as a prognostic indicator. We addressed whether other nonstructural viral proteins, not incorporated into the infectious viral particle, specifically the viral cysteine-like protease, might also be potent immunogens. Using ELISA tests, coating several SARS-CoV-2 proteins produced in vitro, we describe that COVID-19 patients make high titer IgG, IgM, and IgA Ab responses to the Cys-like protease from SARS-CoV-2, also known as 3CLpro or Mpro, and it can be used to identify individuals with positive serology against the coronavirus. Higher Ab titers in these assays associated with more-severe disease, and no cross-reactive Abs against prior betacoronavirus were found. Remarkably, IgG Abs specific for Mpro and other SARS-CoV-2 Ags can also be detected in saliva. In conclusion, Mpro is a potent Ag in infected patients that can be used in serological tests, and its detection in saliva could be the basis for a rapid, noninvasive test for COVID-19 seropositivity., This work was supported by the Spanish National Research Council (Project 202020E079) and grants from the Madrid Regional Government (IMMUNOTHERCAN S2017/BMD-3733-2 [to M.V.-G.]), the Spanish Ministry of Science and Innovation (MCIU/AEI/FEDER, EU: RTI2018-093569-B-I00 [to M.V.-G.], SAF2017-82940-R [to J.M.R.F.], SAF2017-83265-R [to H.T.R.], and SAF2017-82886-R [to F.S.-M.]), and RETICS Program of Instituto de Salud Carlos III (RD16/0012/0006; RIER [to J.M.R.F.], RD16/0011/0012 and PI18/0371 [to I.G.-A.], and PI19/00549 [to A.A.]). The study was also funded by La Caixa Banking Foundation (HR17-00016 to F.S.-M.) and Banco Santander Supera COVID to F.S.-M. This work has been cofunded by grant Covid 2019 from the Madrid Regional Government to Health Institute “La Princesa.”, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Editorial: Atypical Functions of Leukocyte Chemoattractant Receptors

  • Rodríguez-Fernández, José Luis
  • Mellado, Mario
  • Thelen, Marcus
  • Murphy, Philip M.
© 2020 Rodríguez-Fernández, Mellado, Thelen and Murphy., Chemoattraction is a process that involves directed cell movement toward extracellular chemical stimuli. It is a fundamental feature of all biological systems that was discovered in the late nineteenth century, when the word “chemotaxis” was coined by the German biologist Wilhelm Pfeffer. Metchnikoff’s 1882 description of macrophages from starfish larvae migrating toward an implanted rose thorn irritant represents a seminal observation of chemoattraction in vivo. Since then immunologists have described many chemoattractants, including nucleotides, adenosine, lipids (e.g., leukotrienes, prostaglandins, and platelet-activating factor), proteolytic fragments of complement proteins (e.g., C3a and C5a), small peptides (e.g., N-formyl peptides), and small proteins (e.g., chemokines, non-chemokine cytokines, and defensins). Chemokines comprise the largest known group of chemoattractants (1, 2)., Work supported by grants SAF2017-83306-R (MICIU) and RIER (RETICS Program/ISCIII) (RD08/0075) (JLR-F); grants SAF2017-82940-R AEI/FEDER, UE and RD12/0012/0006 (RETICS Program/ISCIII) (MM); grants from the SNSF (310030_163336/1 and Sinergia CRSII3_160719) and Helmut Horten Foundation (MT); and supported in part by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH (PMM).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Growth Hormone Reprograms Macrophages toward an Anti-Inflammatory and Reparative Profile in an MAFB-Dependent Manner

  • Soler Palacios, Blanca
  • Nieto, Concha
  • González de la Aleja, Arturo
  • Andrés, Nuria de
  • Domínguez-Soto, Ángeles
  • Lucas, Pilar
  • Cuenda, Ana
  • Rodríguez-Frade, José Miguel
  • Martínez-Alonso, Carlos
  • Villares, Ricardo
  • Corbí, Angel L.
  • Mellado, Mario
Growth hormone (GH), a pleiotropic hormone secreted by the pituitary gland, regulates immune and inflammatory responses. In this study, we show that GH regulates the phenotypic and functional plasticity of macrophages both in vitro and in vivo. Specifically, GH treatment of GM-CSF–primed monocyte–derived macrophages promotes a significant enrichment of anti-inflammatory genes and dampens the proinflammatory cytokine profile through PI3K-mediated downregulation of activin A and upregulation of MAFB, a critical transcription factor for anti-inflammatory polarization of human macrophages. These in vitro data correlate with improved remission of inflammation and mucosal repair during recovery in the acute dextran sodium sulfate–induced colitis model in GH-overexpressing mice. In this model, in addition to the GH-mediated effects on other immune cells, we observed that macrophages from inflamed gut acquire an anti-inflammatory/reparative profile. Overall, these data indicate that GH reprograms inflammatory macrophages to an anti-inflammatory phenotype and improves resolution during pathologic inflammatory responses., This work was supported in part by grants from the Spanish Ministry of Science, Innovation and Universities (SAF2017-82940-R Agencia Estatal de Investigación/Fondo Europeo de Desarrollo Regional (AEI/FEDER), Unión Europea [UE] [to M.M.], SAF2017-83785-R AEI/FEDER, UE [to Á.L.C.] and FJCI-2016-29990 AEI/FEDER, UE [to B.S.P.]), from the Redes Temáticas de Investigación Cooperativa en Salud Program of Instituto de Salud Carlos III (RD12/0012/0006 and RD12/0012/0007, Red de Investigación en Inflamación y Enfermedades Reumáticas), and the Regional Government of Madrid (B2017/BMD-3804 [to C.M.-A.]).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Otros (Other)

Bead-assisted SARS-CoV-2 multi-antigen serological test allows effective identification of patients

  • Cáceres-Martell, Yaiza
  • Fernández-Soto, Daniel
  • Campos-Silva, Carmen
  • García-Cuesta, Eva María
  • Casasnovas, José María
  • Navas-Herrera, David
  • Beneítez-Martínez, Alexandra
  • Martinez-Fleta, Pedro
  • Alfranca, Arántzazu
  • Sánchez-Madrid, Francisco
  • Escudero López, Gabriela
  • Vilches, Carlos
  • Jara-Acevedo, Ricardo
  • Reyburn, H. T.
  • Rodríguez-Frade, José Miguel
  • Valés-Gómez, Mar
Many new aspects of COVID-19 disease, including different clinical manifestations, have been identified during the pandemic. The wide array of symptoms and variation in disease severity after SARS-CoV-2 infection might be related to heterogeneity in the immune responses of different patients. Here we describe a new method for a simple multi-antigen serological test that generates a full picture of seroconversion in a single reaction. The assay is based on the detection by flow cytometry of multiple immunoglobulin classes (isotypes) specific for four SARS-CoV-2 antigens: the Spike glycoprotein (one of the highly immunogenic proteins), its RBD fragment (the major target for neutralising antibodies), the nucleocapsid protein and the main cysteine-like protease. Until now, most diagnostic serological tests measured antibodies to only one antigen and some patients seemed to not make any antibody response. Our data reveal that while most patients respond against all the viral antigens tested, others show a marked bias to make antibodies against either proteins exposed on the viral particle or those released after cellular infection. Combining all the four antigens and using machine learning techniques, it was possible to clearly discriminate between patients and healthy controls with 100% confidence. Further, combination of antigens and different immunoglobulin isotypes in this multi-antigen assay improved the classification of patients with mild and severe disease. Introduction of this method will facilitate massive screenings of patients to evaluate their immune response. It could also support vaccination campaigns both to select non-immune individuals and to distinguish infected patients from vaccine responders., This work was supported by the Spanish National Research Council (CSIC, project numbers 202020E079 and CSIC-COVID19-028) and grants from Madrid Regional Government “IMMUNOTHERCAN” [S2017/BMD-3733-2 (MVG)]; the Spanish Ministry of Science and Innovation [(MCIU/AEI/FEDER, EU): RTI2018-093569-B-I00 (MVG), SAF2017-82940-R (JMRF), SAF2017-83265-R (HTR); SAF2017-82886-R (FSM)]; Health Institute Carlos III (ISCIII) [RETICS Program RD16/0012/0006; RIER (JMRF); PI19/00549 (AA)]. The study was also funded by “La Caixa Banking Foundation” (HR17-00016 to FSM) and Fondo Supera COVID (CRUE-Banco de Santander) to FSM., No
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

The multilayered complexity of the chemokine receptor system

  • D’Agostino, Gianluca
  • García-Cuesta, Eva María
  • Gomariz, Rosa P.
  • Rodríguez-Frade, José Miguel
  • Mellado, Mario
The chemokines receptor family are membrane-expressed class A-specific seven-transmembrane receptors linked to G proteins. Through interaction with the corresponding ligands, the chemokines, they induce a wide variety of cellular responses including cell polarization, movement, immune and inflammatory responses, as well as the prevention of HIV-1 infection. Like a Russian matryoshka doll, the chemokine receptor system is more complex than initially envisaged. This review focuses on the mechanisms that contribute to this dazzling complexity and how they modulate the signaling events triggered by chemokines. The chemokines and their receptors exist as monomers, dimers and oligomers, their expression pattern is highly regulated, and the ligands can bind distinct receptors with similar affinities. The use of novel imaging-based technologies, particularly real-time imaging modalities, has shed new light on the very dynamic conformations that chemokine receptors adopt depending on the cellular context, and that affect chemokine-mediated responses. This complex scenario presents both challenging and exciting opportunities for drug discovery., This work was supported in part by grants from the Spanish Ministry of Science, Innovation and Universities (SAF2017-82940-R), and the RETICS Program of ISCIII (RD16/0012/0006 and RD16/0012/0008; RIER).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Image Processing Protocol for the Analysis of the Diffusion and Cluster Size of Membrane Receptors by Fluorescence Microscopy

  • Sorzano, Carlos Óscar S.
  • Cascio, Graciela
  • García-Cuesta, Eva María
  • Vargas, Javier
  • Mellado, Mario
  • Rodríguez, Jose Miguel
Particle tracking on a video sequence and the posterior analysis of their trajectories is nowadays a common operation in many biological studies. Using the analysis of cell membrane receptor clusters as a model, we present a detailed protocol for this image analysis task using Fiji (ImageJ) and Matlab routines to: 1) define regions of interest and design masks adapted to these regions; 2) track the particles in fluorescence microscopy videos; 3) analyze the diffusion and intensity characteristics of selected tracks. The quantitative analysis of the diffusion coefficients, types of motion, and cluster size obtained by fluorescence microscopy and image processing provides a valuable tool to objectively determine particle dynamics and the consequences of modifying environmental conditions. In this article we present detailed protocols for the analysis of these features. The method described here not only allows single-molecule tracking detection, but also automates the estimation of lateral diffusion parameters at the cell membrane, classifies the type of trajectory and allows complete analysis thus overcoming the difficulties in quantifying spot size over its entire trajectory at the cell membrane., This work was supported in part by grants from the Spanish Ministry of Science, Innovation and Universities (SAF 2017-82940-R) and the RETICS Program of the Instituto de salud Carlos III (RD12/0009/009 and RD16/0012/0006; RIER). LMM and JV are supported by the COMFUTURO program of the Fundación General CSIC.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Wnt and RUNX2 mediate cartilage breakdown by osteoarthritis synovial fibroblast-derived ADAMTS-7 and -12

  • Pérez-García, Selene
  • Carrión, Mar
  • Villanueva-Romero, Raúl
  • Hermida-Gómez, Tamara
  • Fernández-Moreno, Mercedes
  • Mellado, Mario
  • Blanco, Francisco J.
  • Juarranz, Yasmina
  • Gomariz, Rosa P.
© 2019 The Authors., Failure of therapeutic approaches for the treatment of osteoarthritis (OA) based on the inhibition of metalloproteinases, might be because of their constitutive expression in homeostasis, together with their network complexity. The knowledge of this network would contribute to selective target pathological conditions. In this sense, blockade of mediators produced by neighbouring joint cells, such as synovial fibroblasts (SF), would prevent cartilage damage. Thus, we studied the contribution of ADAMTS-7 and -12 from SF to cartilage oligomeric matrix protein (COMP) degradation, and the signalling pathways involved in their expression. We report for the first time in SF, the involvement of ERK-Runx2 axis and Wnt/β-catenin signalling in ADAMTS-12 and ADAMTS-7 expressions, respectively, with the subsequent consequences in COMP degradation from cartilage extracellular matrix. After stimulation with IL-1β or fibronectin fragments, we showed that ERK inhibition decreased Runx2 activation and ADAMTS-12 expression in OA-SF, also reducing Fn-fs-induced COMP degradation. Blockage of Wnt signalling by DKK1 reduced ADAMTS-7 and COMP degradation in OA-SF as well. In addition, Wnt7B expression was induced by IL-1β and by itself, also increasing ADAMTS-7. Our results could contribute to the development of disease-modifying OA drugs targeting ADAMTS-7 and -12 for the prevention of extracellular matrix components degradation like COMP., This work has been supported by Instituto de Salud Carlos III, Spain, cofinanced by FEDER, European Union: RETICS program, Red de Investigación en Inflamación y Enfermedades Reumáticas (RD16/0012/0002 RD16/0012/0006 and RD16/0012/0008), the project SAF 2017‐82940‐R, and the projects PI17/00027 and PI16/2124 integrated in the National Plan for Scientific Program, Development and Technological Innovation and Funded by ISCIII‐General Subdirection of Assessment and Promotion of Research‐European Regional Development Fund (FEDER) “A way of making Europe”. MFM was supported by CIBER (CB06/01/0040).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Single-reaction multi-antigen serological test for comprehensive evaluation of SARS-CoV-2 patients by flow cytometry

  • Cáceres-Martell, Yaiza
  • Fernández-Soto, Daniel
  • Campos-Silva, Carmen
  • García-Cuesta, Eva María
  • Casasnovas, José María
  • Navas-Herrera, David
  • Beneítez-Martínez, Alexandra
  • Martinez-Fleta, Pedro
  • Alfranca, Arántzazu
  • Sánchez-Madrid, Francisco
  • Escudero López, Gabriela
  • Vilches, Carlos
  • Jara-Acevedo, Ricardo
  • Reyburn, H. T.
  • Rodríguez-Frade, José Miguel
  • Valés-Gómez, Mar
Here, we describe a new, simple, highly multiplexed serological test that generates a more complete picture of seroconversion than single antigen-based assays. Flow cytometry is used to detect multiple Ig isotypes binding to four SARS-CoV-2 antigens: the Spike glycoprotein, its RBD fragment (the main target for neutralizing antibodies), the nucleocapsid protein, and the main cysteine-like protease in a single reaction. Until now, most diagnostic serological tests measured antibodies to only one antigen and in some laboratory-confirmed patients no SARS-CoV-2-specific antibodies could be detected. Our data reveal that while most patients respond against all the viral antigens tested, others show a marked bias to make antibodies against either proteins exposed on the viral particle or those released after cellular infection. With this assay, it was possible to discriminate between patients and healthy controls with 100% confidence. Analysing the response of multiple Ig isotypes to the four antigens in combination may also help to establish a correlation with the severity degree of disease. A more detailed description of the immune responses of different patients to SARS-CoV-2 virus might provide insight into the wide array of clinical presentations of COVID-19., This work was supported by: Spanish National Research Council (CSIC-202020E079, CSIC-COVID19-028); Madrid Regional Government “IMMUNOTHERCAN” [S2017/BMD-3733-2 (MVG)]; Spanish Ministry of Science and Innovation [(MCIU/AEI/FEDER, EU, RTI2018-093569-B-I00 (MVG), SAF2017-82940-R (JMRF), SAF2017-83265-R (HTR); SAF2017-82886-R (FSM)]; Health Institute Carlos III (ISCIII) [RETICS Program RD16/0012/0006; RIER (EMGC); PI19/00549 (AA)]; “La Caixa Bank Foundation” (HR17-00016), Fondo Supera COVID (CRUE-Banco de Santander), both to FSM., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Cross-reactive cellular, but not humoral, immunity is detected between OC43 and SARS-CoV-2 NPs in people not infected with SARS-CoV-2: Possible role of cTFH cells

  • García-Jiménez, Álvaro Fernando
  • Cáceres-Martell, Yaiza
  • Fernández-Soto, Daniel
  • Martinez-Fleta, Pedro
  • Casasnovas, José María
  • Sánchez-Madrid, Francisco
  • Rodríguez-Frade, José Miguel
  • Valés-Gómez, Mar
  • Reyburn, H. T.
Multiple questions about SARS-CoV-2 humoral and cellular immunity remain unanswered. One key question is whether preexisting memory T or B cells, specific for related coronaviruses in SARS-CoV-2-unexposed individuals, can recognize and suppress COVID-19, but this issue remains unclear. Here, we demonstrate that antibody responses to SARS-CoV-2 antigens are restricted to serum samples from COVID-19 convalescent individuals. In contrast, cross-reactive T cell proliferation and IFN-γ production responses were detected in PBMCs of around 30% of donor samples collected prepandemic, although we found that these prepandemic T cell responses only elicited weak cTFH activation upon stimulation with either HCoV-OC43 or SARS-CoV-2 NP protein. Overall, these observations confirm that T cell cross-reactive with SARS-CoV-2 antigens are present in unexposed people, but suggest that the T cell response to HCoV-OC43 could be deficient in some important aspects, like TFH expansion, that might compromise the generation of cross-reactive TFH cells and antibodies. Understanding these differences in cellular responses may be of critical importance to advance in our knowledge of immunity against SARS-CoV-2., This work was supported by the Spanish National Research Council (CSIC, project numbers 202020E079 and CSIC-COVID19-028)and grants from Madrid Regional Government “IMMUNOTHERCAN”[S2017/BMD-3733-2(M.V.G.)];the Spanish Ministry of Science and Innovation [(MCIU/AEI/FEDER,EU):RTI2018-093569-B-I00(M.V.G.),SAF2017-82940-R(J.M.R.F.),SAF2017-83265-R(H.T.R.);SAF2017-82886-R(F.S.M.)];RETICSProgramofISCIII[RD16/0012/0006;RIER(J. M. R. F.)]. A. F. G. J. is a recipient of a fellowship (FPU18/01698)from the Spanish Ministry of Science and Education.D.F.S.isarecip-ientofafellowship (PRE2018-083200)from the Spanish Ministry of Science and Innovation. Both are graduate students in the Molecular Biosciences doctoral program of the Autonomous University of Madrid, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Altered CXCR4 dynamics at the cell membrane impairs directed cell migration in WHIM syndrome patients

  • García-Cuesta, Eva M.
  • Rodríguez-Frade, José Miguel
  • Gardeta, Sofía R.
  • D'Agostino, Gianluca
  • Arranz-Martínez, Pablo
  • Soler Palacios, Blanca
  • Cascio, Graciela
  • Wolf, Tobias
  • Mateos, Nicolas
  • Ayala-Bueno, Rosa
  • Santiago, César A.
  • Lucas, Pilar
  • Llorente, Lucia
  • Allende, Luis M.
  • González-Granado, Luis Ignacio
  • Martín-Cófreces, Noa
  • Roda-Navarro, Pedro
  • Sallusto, Federica
  • Sánchez-Madrid, Francisco
  • García-Parajo, María F.
  • Martínez-Muñoz, Laura
  • Mellado, Mario
Chemokine receptor nanoscale organization at the cell membrane is orchestrated by the actin cytoskeleton and influences cell responses. Using single-particle tracking analysis we show that CXCR4R334X, a truncated mutant chemokine receptor linked to WHIM syndrome (warts, hypogammaglobulinemia, infections, myelokathexis), fails to nanoclusterize after CXCL12 stimulation, and alters the lateral mobility and spatial organization of CXCR4 when coexpressed. These findings correlate with multiple phalloidin-positive protrusions in cells expressing CXCR4R334X, and their inability to correctly sense chemokine gradients. The underlying mechanisms involve inappropriate actin cytoskeleton remodeling due to the inadequate β-arrestin1 activation by CXCR4R334X, which disrupts the equilibrium between activated and deactivated cofilin. Overall, we provide insights into the molecular mechanisms governing CXCR4 nanoclustering, signaling and cell function, and highlight the essential scaffold role of β-arrestin1 to support CXCL12-mediated actin reorganization and receptor clustering. These defects associated with CXCR4R334X expression might contribute to the severe immunological symptoms associated with WHIM syndrome., This work was supported by grants from the Spanish Ministry of Science and Innovation (SAF 2017-82940-R and PID2020-114980RB-I00) and the Redes Temáticas de Investigación Cooperativa en Salud Program (RD12/0009/009; Red de inflamación y Enfermedades Reumáticas [RIER]). L.I.G.-G. is supported by a grant of Fondo de Investigaciones Sanitarias PI21/01642; F.S. and the Institute for Research in Biomedicine are supported by the Helmut Horten Foundation; L.M.-M. is supported by the JIN program from the Spanish Ministry of Science and Innovation (RT12018-101789-J-100). N.M. and M.F.G.-P. acknowledge funding from the European Union H2020 under the Marie Sklodowska-Curie Grant 754558-PREBIST (to N.M.) and European Research Council Grant 788546-NANO-MEMEC (to M.F.G.-P.)., Peer reviewed